콘텐츠로 건너뛰기
Merck
  • In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.

In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.

Bioorganic & medicinal chemistry letters (2010-12-07)
Rosanna Maccari, Antonella Del Corso, Marco Giglio, Roberta Moschini, Umberto Mura, Rosaria Ottanà
초록

2-Thioxo-4-thiazolidinone derivatives were evaluated as aldose reductase inhibitors (ARIs) and most of them exhibited good or excellent in vitro efficacy. Out of the tested compounds, most N-unsubstituted analogues were found to possess inhibitory effects at low micromolar doses and two of them exhibited higher potency than sorbinil, used as a reference drug. The insertion of an acetic chain on N-3 of the thiazolidinone scaffold led to analogues with submicromolar affinity for ALR2 and IC(50) values very similar to that of epalrestat, the only ARI currently used in therapy.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Sorbinil, ≥98% (HPLC)